logo
Select company
Select metric
-107.1%EBIT Margin
VS
Market
12
Sector
38
Industry
66
History
71
$ 3.11Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -4.51M-107.1%$ 4.21M
3/31/2025$ -5.37M-146.11%$ 3.67M
12/31/2024$ 9.03K0.08%$ 11.2M
9/30/2024$ -4.05M-51.18%$ 7.92M
6/30/2024$ -8.49M-176.78%$ 4.8M
3/31/2024$ -8.97M-190.34%$ 4.71M
12/31/2023$ -16.35M0%$ -2.85M
9/30/2023$ -16.3M0%$ -3.07M
6/30/2023$ -12.06M-21926.27%$ 54.99K
3/31/2023$ -11.13M-2005.95%$ 554.99K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, LIPOCINE INC's average EBIT % has been -4183.05%.
  • The median EBIT % for LIPOCINE INC during this period was -126.61%
  • LIPOCINE INC reached its highest EBIT % over the past 5 years at 25.05%.
  • The lowest EBIT % recorded by LIPOCINE INC in the same timeframe -31852.79%

LIPOCINE INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
MRKR : MARKER THERAPEUTICS INC -270.18%BOLT : BOLT BIOTHERAPEUTICS INC -1217.01%TRAW : TRAWS PHARMA INC 3028.25%NRXS : NEURAXIS INC -220.34%LGVN : LONGEVERON INC -894.31%XAIR : BEYOND AIR INC -826.24%DYAI : DYADIC INTERNATIONAL INC -123.19%INM : INMED PHARMACEUTICALS INC -157.62%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%INBS : INTELLIGENT BIO SOLUTIONS INC -271.56%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for LIPOCINE INC is calculated as follows: EBIT [ $ -20.05M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

LPCN - EBIT Margin, Last 5 years

-31852.79%

Minimum

Sep 30, 2021

25.05%

Maximum

Sep 30, 2022

-4183.05%

Average

-126.61%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%